Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrew S. Palm
Andrew S. Palm
Pfizer
Chemistry
Organic chemistry
Active ingredient
Calibration
Process engineering
6
Papers
25
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Palbociclib Commercial Manufacturing Process Development. Part II: Regioselective Heck Coupling with Polymorph Control for Processability
2016
Organic Process Research & Development
Mark T. Maloney
Brian P. Jones
Mark Olivier
Javier Magano
Ke Wang
Nathan D. Ide
Andrew S. Palm
David R. Bill
Kyle R. Leeman
Karen Sutherland
John Draper
Adrian M. Daly
Joseph Keane
Denis Lynch
Marie O’Brien
Joanne Tuohy
Show All
Source
Cite
Save
Citations (15)
Development of the Commercial Route for the Manufacture of a 5-Lipoxygenase Inhibitor PF-04191834
2015
Organic Process Research & Development
Brian Patrick Chekal
David B. Damon
Danny Lafrance
Kyle R. Leeman
Carlos Mojica
Andrew S. Palm
Michael St. Pierre
Janice E. Sieser
Karen Sutherland
Rajappa Vaidyanathan
John Van Alsten
Brian C. Vanderplas
Carrie Wager
Gerald A. Weisenburger
Gregory J. Withbroe
Shu Yu
Show All
Source
Cite
Save
Citations (6)
Development of Migita Couplings for the Manufacture of a 5‐Lipoxygenase Inhibitor
2013
Weiling Cai
Brian Patrick Chekal
David B. Damon
Danny Lafrance
Kyle R. Leeman
Carlos Mojica
Andrew S. Palm
Michael St. Pierre
Janice E. Sieser
Karen Sutherland
Rajappa Vaidyanathan
John Van Alsten
Brian C. Vanderplas
Carrie Wager
Gerald A. Weisenburger
Greg Withbroe
Shu Yu
Show All
Source
Cite
Save
Citations (1)
Monitoring the dissolution of active pharmaceutical ingredient and TPGS in real time via IR spectroscopy during the manufacturing of liquid dosage formulation
2012
Journal of Pharmaceutical and Biomedical Analysis
Slobodan Šašiċ
Andrew S. Palm
Degui Tang
Show All
Source
Cite
Save
Citations (0)
1